| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.032 | 0.5 |